Medicure (MCUJF) Expected to Post Quarterly Earnings on Wednesday

Medicure (OTCMKTS:MCUJF) is expected to be issuing its results after the market closes on Wednesday, August 19th. Analysts expect Medicure to announce earnings of ($0.0474) per share and revenue of $2.4460 million for the quarter.

Medicure (OTCMKTS:MCUJF) last posted its quarterly earnings data on Thursday, May 21st. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.01. Medicure had a negative return on equity of 44.34% and a negative net margin of 21.65%.The firm had revenue of $5.79 million for the quarter, compared to the consensus estimate of $3.63 million.

Medicure Price Performance

MCUJF opened at $0.85 on Wednesday. The stock’s 50-day moving average price is $0.76 and its 200 day moving average price is $0.81. Medicure has a 12-month low of $0.67 and a 12-month high of $0.97. The firm has a market cap of $8.87 million, a price-to-earnings ratio of -1.81 and a beta of 0.99. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.03.

Medicure Company Profile

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical?care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.